Breaking News Headlines Today

News from Interventional News

See all of Interventional News news coverage in one place. Discover how Interventional News’s media bias informs their coverage and compare with thousands of other news outlets.

We’ve discovered 56 headlines written by Interventional News during the past 3 months.

The Ground News media bias check for Interventional News is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

Interventional News’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Interventional News

Where is Interventional News located?Interventional News's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Interventional News News

Portage, Michigan · Portage

Inari Medical, Now Part of Stryker, Launches InThrill Thrombectomy System - Interventional News

100% Center coverage: 4 sources

InThrill thrombectomy system Inari Medical—now part of Stryker—has today announced the launch of its next-generation InThrill thrombectomy system. The company has stated in a recent press release that this is the first and only purpose-built small vessel and arteriovenous (AV) access thrombectomy system that can deliver fast, full luminal clot removal. The second generation InThrill thrombectomy system is an 8Fr over-the-wire system comprising t…See the Story

AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia

100% Center coverage: 1 sources

LATHAM, N.Y.--(BUSINESS WIRE)--Jul 28, 2025-See the Story

Technology · United Kingdom

MHRA Announces Proposals to Improve Access to World’s Best Medical Devices for Patients and to Boost Economic Growth in Britain’s Med Tech Sector

The MHRA has now published the government’s response to its public consultation on future routes to market for medical devices - designed to modernise regulation See the Story

CGuard Prime carotid stent gains US and European approvals for stroke prevention

InspireMD has been granted premarket approval (PMA) from the US Food and Drug Administration (FDA) for its CGuard Prime carotid stent system in the USA—news that follows the company’s recent announcement of CE-mark approval under the European Medical Device Regulation (MDR). “The C-GUARDIANS clinical trial provides strong scientific evidence to support the neuroprotective benefits of the next-generation MicroNet mesh technology of the CGuard Pri…FDA · Columbus Read Article

Post-conversion curative microwave ablation shows comparable survival to initially ablatable colorectal liver metastases - Interventional News

Initially unablatable patients with synchronous colorectal liver metastases (sCRLM) who successfully converted to ablatable status and underwent curative-intent microwave ablation (c-MWA) achieve comparable intrahepatic progression-free survival (ihPFS) and overall survival (OS) to initially ablatable cases undergoing radical MWA (r-MWA). These were the conclusions drawn from a recent study published in the journal Clinical Radiology led by Liem…Guangdong · Guangdong Read Article

SIO announces early enrolment completion for ACCLAIM trial - Interventional News

The Society of Interventional Oncology (SIO) has today announced the successful early completion of enrolment for the Ablation with Confirmation of Colorectal Liver Metastases (ACCLAIM) trial. The society states that this milestone was achieved in a record eight months ahead of schedule. “Reaching our enrolment target eight months ahead of schedule reflects the strategic coordination and commitment driving the ACCLAIM trial—from our dedicated st…New York State · New York Read Article

Philips receives FDA 510(k) clearance for image-guided navigation system for prostate cancer - Interventional News

Philips UroNav Philips has announced the FDA 510(k) clearance of the latest Philips UroNav system. In a recent press release made by the company, it states that the system includes a new advanced annotation workflow that supports clinicians during focal therapy procedures, helping deliver more precise, minimally invasive care. “We’re entering a new era of precision prostate cancer care. Philips’ integrated focal therapy platform unifies imaging,…New York City · New York Read Article

Breakthrough Prostate Cancer Treatment Preserves Sexual Function in 84% of Patients, New Study Reveals

European Urology publishes PRESERVE trial results showing NanoKnife System's effectiveness in prostate cancer treatment with quality-of-life preservation. See full data.United States · United States See the Story

EMBO-02 Study Indicates Rapid cSDH Resorption and Pain-Free Treatments with NeoCast Liquid Embolic Agent

Arsenal Medical has announced late-breaking data from the EMBO-02 clinical study evaluating NeoCast—a next-generation, shear-responsive liquid embolic agent—in the treatment of patients with chronic subdural haematoma (cSDH) via middle meningeal artery embolisation (MMAe). Research presented across multiple sessions at the Society of NeuroInterventional Surgery (SNIS) annual meeting (14–18 July, Nashville, USA) showed that all patients met prima…Arsenal FC · Western Australia See the Story

First Subject Enrolled in Trial of Medtronic’s Liquid Embolic System

Medtronic has announced the first subject enrolment in the PELE trial, aiming to assess the Onyx liquid embolic system (LES).The post First subject enrolled in trial of Medtronic’s liquid embolic system appeared first on Medical Device Network.Albany, New York · Albany See the Story

Varian launches microwave ablation system for soft tissue tumours in Europe

Varian has introduced the next-generation microwave ablation solution, IntelliBlate, in Europe to treat soft tissue tumours.The post Varian launches microwave ablation system for soft tissue tumours in Europe appeared first on Medical Device Network.See the Story

News from Interventional News

News from Interventional News

Information about Interventional News

Media Bias Ratings

Factuality

Ownership

Top Interventional News News

Inari Medical, Now Part of Stryker, Launches InThrill Thrombectomy System - Interventional News

AngioDynamics Enrolls First Patient in AMBITION BTK Trial Advancing Treatment for Critical Limb Ischemia

MHRA Announces Proposals to Improve Access to World’s Best Medical Devices for Patients and to Boost Economic Growth in Britain’s Med Tech Sector

CGuard Prime carotid stent gains US and European approvals for stroke prevention

Post-conversion curative microwave ablation shows comparable survival to initially ablatable colorectal liver metastases - Interventional News

SIO announces early enrolment completion for ACCLAIM trial - Interventional News

Philips receives FDA 510(k) clearance for image-guided navigation system for prostate cancer - Interventional News

Breakthrough Prostate Cancer Treatment Preserves Sexual Function in 84% of Patients, New Study Reveals

EMBO-02 Study Indicates Rapid cSDH Resorption and Pain-Free Treatments with NeoCast Liquid Embolic Agent

First Subject Enrolled in Trial of Medtronic’s Liquid Embolic System

Varian launches microwave ablation system for soft tissue tumours in Europe

Similar News Topics

Topics Most Covered by Interventional News

Sources Covering Similar Topics

Breaking News Topics Related to Interventional News

Information about Interventional News

Media Bias Ratings

Factuality

Ownership

CGuard Prime carotid stent gains US and European approvals for stroke prevention

Post-conversion curative microwave ablation shows comparable survival to initially ablatable colorectal liver metastases - Interventional News

SIO announces early enrolment completion for ACCLAIM trial - Interventional News

Philips receives FDA 510(k) clearance for image-guided navigation system for prostate cancer - Interventional News

Breakthrough Prostate Cancer Treatment Preserves Sexual Function in 84% of Patients, New Study Reveals

EMBO-02 Study Indicates Rapid cSDH Resorption and Pain-Free Treatments with NeoCast Liquid Embolic Agent

First Subject Enrolled in Trial of Medtronic’s Liquid Embolic System

Varian launches microwave ablation system for soft tissue tumours in Europe